Plasma concentrations of apolipoproteins A-I, B and M in patients with abdominal aortic aneurysms

Clinical Biochemistry

Volumn 43, Issue 4-5, 2010, Pages 407-410

  Ahnström, Josefin ^a   Gottsäter, Anders ^b   Lindblad, Bengt ^b   Dahlbäck, Björn ^a  

^a Clinical Chemistry ^*  (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

AAA; Aneurysmal disease; ApoA I; ApoB; Apolipoprotein; ApoM; HDL; Lipocalin; Lipoprotein; Signal peptide

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN M; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ELDERLY CARE; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT;

AGED; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; APOLIPOPROTEINS B; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS;

EID: 76749120943     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.11.006     Document Type: Article

References (25)

1. Golledge J., Muller J., Daugherty A., and Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2605-2613
2. Blanchard J.F., Armenian H.K., and Friesen P.P. Risk factors for abdominal aortic aneurysm: results of a case-control study. Am. J. Epidemiol. 151 (2000) 575-583
3. Lindblad B., Borner G., and Gottsater A. Factors associated with development of large abdominal aortic aneurysm in middle-aged men. Eur. J. Vasc. Endovasc. Surg. 30 (2005) 346-352
4. Wanhainen A., Bergqvist D., Boman K., Nilsson T.K., Rutegard J., and Bjorck M. Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. J. Vasc. Surg. 41 (2005) 390-396
5. Hobbs S.D., Claridge M.W., Quick C.R., Day N.E., Bradbury A.W., and Wilmink A.B. LDL cholesterol is associated with small abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 26 (2003) 618-622
6. Schlosser F.J., Tangelder M.J., Verhagen H.J., van der Heijden G.J., Muhs B.E., van der Graaf Y., and Moll F.L. Growth predictors and prognosis of small abdominal aortic aneurysms. J. Vasc. Surg. 47 (2008) 1127-1133
7. Choke E., Cockerill G., Wilson W.R., Sayed S., Dawson J., Loftus I., and Thompson M.M. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur. J. Vasc. Endovasc. Surg. 30 (2005) 227-244
8. Simoni G., Gianotti A., Ardia A., Baiardi A., Galleano R., and Civalleri D. Screening study of abdominal aortic aneurysm in a general population: lipid parameters. Cardiovasc. Surg. 4 (1996) 445-448
9. Rizzo M., Krayenbuhl P.A., Pernice V., Frasheri A., Battista Rini G., and Berneis K. LDL size and subclasses in patients with abdominal aortic aneurysm. Int. J. Cardiol. (2008)
10. Golledge J., Tsao P.S., Dalman R.L., and Norman P.E. Circulating markers of abdominal aortic aneurysm presence and progression. Circulation 118 (2008) 2382-2392
11. Forsdahl S.H., Singh K., Solberg S., and Jacobsen B.K. Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromso Study, 1994-2001. Circulation 119 (2009) 2202-2208
12. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
13. Xu N., and Dahlback B. A novel human apolipoprotein (apoM). J. Biol. Chem. 274 (1999) 31286-31290
14. Christoffersen C., Nielsen L.B., Axler O., Andersson A., Johnsen A.H., and Dahlback B. Isolation and characterization of human apolipoprotein M-containing lipoproteins. J. Lipid Res. 47 (2006) 1833-1843
15. Axler O., Ahnstrom J., and Dahlback B. An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma. J. Lipid Res. 48 (2007) 1772-1780
16. Ahnstrom J., et al. Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies. J. Lipid Res. 49 (2008) 1912-1917
17. Christoffersen C., Jauhiainen M., Moser M., Porse B., Ehnholm C., Boesl M., Dahlback B., and Nielsen L.B. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. J. Biol. Chem. 283 (2008) 1839-1847
18. Wolfrum C., Poy M.N., and Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11 (2005) 418-422
19. Nilsson P., and Berglund G. Prevention of cardiovascular disease and diabetes: lessons from the Malmo Preventive Project. J. Intern. Med. 248 (2000) 455-462
20. Flondell-Site D., Lindblad B., Kolbel T., and Gottsater A. Cytokines and systemic biomarkers are related to the size of abdominal aortic aneurysms. Cytokine 46 (2009) 211-215
21. Team R.D.C. R: A Language and Environment for Statistical Computing. (2009), R Foundation for Statistical Comuting, Vienna, Austria
22. Ritchie R.F., Palomaki G.E., Neveux L.M., Ledue T.B., Craig W.Y., Marcovina S., and Navolotskaia O. Reference distributions for apolipoproteins AI and B and the apolipoprotein B/AI ratios: a practical and clinically relevant approach in a large cohort. J. Clin. Lab. Anal. 20 (2006) 209-217
23. Contois J., McNamara J.R., Lammi-Keefe C., Wilson P.W., Massov T., and Schaefer E.J. Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin. Chem. 42 (1996) 507-514
24. Jungner I., Marcovina S.M., Walldius G., Holme I., Kolar W., and Steiner E. Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin. Chem. 44 (1998) 1641-1649
25. Andrikoula M., and McDowell I.F. The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment. Diabetes Obes. Metab 10 (2008) 271-278